Weekly News

Venture Category: Biotechnology


This week's biotechnology venture startup news



ADURO - How To Use a Flourishing Assessment to Help Employees Find Purpose at Work (Feb 18 2021)
Have you ever dreaded going into work on Monday? Do you struggle to find a data collection method that measures how well or happy your employees are? (We can’t see you, but we’re pretty sure you’re vigorously nodding your head.) Nearly 76 percent of U.S. respondents felt the same way — st...
    Altavant Sciences - Altavant Sciences Initiates Chemical Lung Injury Program in Collaboration with the BARDA and NIAID (Feb 18 2021)
    Cary, N.C. and Basel, Switzerland – February 18, 2021 – Altavant has partnered with HHS, BARDA and the NIAID to execute an initial in vivo proof-of-concept pilot study of ALTA-2530 for the treatment of lung injuries caused by sulfur mustard inhalation.
    The post 
      Aminex Therapeutics - Sydney Researchers Identify Potential New Drug Treatment Developed by Aminex Therapeutics for Fatal Childhood Cancer (Feb 16 2021)
      SYDNEY RESEARCHERS IDENTIFY POTENTIAL NEW DRUG TREATMENT DEVELOPED BY AMINEX THERAPEUTICS FOR FATAL CHILDHOOD CANCER Combination treatment eradicates DIPG cancer in tumor cell lab models February 16, 2021, Seattle, WA – Every year around 20 Australian children die from the incurable brain tumor, D...
        Adaptive Phage Therapeutics - Downstream Manufacturing Technician (Feb 15 2021)
        POSITION DESCRIPTION: Downstream Manufacturing Technician We are looking for an experienced manufacturing technician to join the downstream manufacturing team at Adaptive Phage Therapeutics (APT). In this position, the candidate will work alongside the purification team to purify batches of bacterio...
          AVEO Pharmaceuticals - Vice President, Medical Affairs (Feb 17 2021)
          Description Reporting to the Chief Medical Officer, the Vice President, Medical Affairs will create and provide strategic vision, leadership, and management for key medical affairs activities, including consistent and aligned medical and scientific communications, cross-functional medical strateg...
            Embark - Dog Teeth: How to Maintain Your Dog’s Dental Health (Feb 19 2021)
            You’ve got the brush-twice-a-day thing down pat for yourself and go to the dentist regularly, but you might be asking, how often should I brush my dog’s teeth? You might also be wondering if a professional should do your dog’s teeth cleaning and if so, what that involves.  Your dog’s den...
              Grid Therapeutics - Coming together at the hinges: Therapeutic prospects of IgG3 (Feb 19 2021)
              The post Coming together at the hinges: Therapeutic prospects of IgG3 appeared first on Grid Therapeutics.
              
                Immunic - Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis (Feb 18 2021)
                – Statistically Significant Decrease in Serum Alkaline Phosphatase (ALP) Levels in the Per-Protocol Population After 24-Week IMU-838 Treatment, as Compared to Baseline – – Primary Objective of Therapeutic Benefit Achieved in 27.3% of the Patients of the Per-Protocol Population at Week 24 ...
                  InCarda Therapeutics - InCarda Therapeutics featured in Men’s Health (Feb 15 2021)
                  InCarda Therapeutics CEO Grace Colón was interviewed for this brief and informative piece on Atrial Fibrillation, The Hidden Heart Problem That’s Claiming Men’s Lives Now by Julie Stewart in the February 2021 edition of Men’s Health. Key points: “There’s a U-shaped curve with AFib...
                    Inimmune - For Missoula’s Inimmune, a $22 M Series A Round with Two Bear Capital is the latest record set – MT High Tech Business Alliance (Feb 15 2021)
                    https://www.mthightech.org/news/inimmune-biotech-case-study
                    The post For Missoula’s Inimmune, a $22 M Series A Rou...
                      Inimmune - Nation angler Evans helping with vital COVID research (Feb 15 2021)
                      <https://www.bassmaster.com/news/nation-angler-evans-helping-vital-covid-research?j=23264113&sfmc_sub=1646391083&l=4168516_HTML&u=507970617&mid=10688361&jb=0>
                      The post 
                        Kura Oncology - Payroll Manager- San Diego, CA (Feb 17 2021)
                        
                        
                          Mindleap Health - Can MDMA Psychotherapy Really Reverse Trauma? (Feb 19 2021)
                          Trauma is a difficult issue that many people have to deal with in modern society. According to The Centre for Addiction and Mental Health, trauma is defined as the lasting emotional response that often results from living through a distressing event (CAMH, n.d.). While sometimes brushed off, thes...
                            MindMed - Can LSD cure our pandemic anxiety? MindMed is spending big to find out (Feb 18 2021)
                            While many people will look back on the pandemic as a dark time, it has also spurred some positive developments—most notably in the field of drug development, where miraculous breakthroughs like mRNA vaccines are transforming immunology. Now, a handful of companies believe the pandemic could ...
                              Nurix - SRA/Scientist I, Purification (Feb 20 2021)
                              We are seeking a highly motivated individual with a 5 or more years of lab experience with a background in purification of small molecule libraries. Experience with gram scale chiral and achiral purification by HPLC and SFC is also desired. This position will perform purifications of small molecu...
                                Nurix - IT Helpdesk Manager (Feb 17 2021)
                                Company Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in...
                                  OncoMyx Therapeutics - OncoMyx to Present at Biocom’s 11th Annual Global Life Sciences Partnering Conference (Feb 19 2021)
                                  PHOENIX, February 19, 2021 – OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, today announced that Steve Potts, Ph.D., MBA, cofounder and chief executive officer of OncoMyx, will give an online presentation on February 23rd at 2 pm PST at Biocom’s 11th Annual Global Lif...
                                    Pear Therapeutics - Pear Announces Indiana Family and Social Services Administration Division of Mental Health and Addiction will Provide Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders (Feb 17 2021)
                                    Through a State Opioid Response (SOR) grant, the Indiana Family and Social Services Administration’s Division of Mental Health and Addiction (DMHA) will provide access to Pear’s reSET® and reSET-O® to patients with substance use disorder and opioid use disorder. Pear and DMHA aim to help Ho...
                                      ProPharma Group - Brexit: New Regulatory Opportunities in the United Kingdom (Feb 18 2021)
                                      As the dust settles on the final Brexit deal, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is forging new opportunities to innovate, increasing its efficiency, and collaborating with global regulators outside Europe. This shifting landscape offers the industry some new st...
                                        ReCode Therapeutics - ReCode Therapeutics to Participate in Upcoming Investor Conferences (Feb 16 2021)
                                        
                                        
                                          SafeTraces - Healthy Air Episode #6 (Feb 19 2021)
                                          Date: February 18, 2021 Episode #6 Improving a building’s impact on human cognition and health | Simon Turner – Founder of Building Cognition LLC In this episode, Simon Turner shares the biggest changes he’s seen in the last thirty years, as he has worked to improve impact ...
                                            SGI DNA - New resource: Biocompare ebook illustrates how life science tools are accelerating COVID-19 research (Feb 17 2021)
                                            It can be tough to keep up on the latest COVID-19 news, but a new ebook from Biocompare is here to help. The ebook offers a nice array of articles focused on how novel tools are being used to accelerate…
                                            The post